Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents

被引:94
作者
Coelho, J [1 ]
Woodford, N [1 ]
Afzal-Shah, M [1 ]
Livermore, D [1 ]
机构
[1] Hlth Protect Agcy Ctr Infect, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England
关键词
D O I
10.1128/AAC.50.2.756-758.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
OXA-58 is a recently described carbapenemase from Acinetobacter spp. in Europe. We examined earlier worldwide Acinetobacter collections and found bla(OXA-58) in 30 carbapenem-nonsusceptible isolates, including several isolates collected in Argentina and Kuwait in 1995 and 1996 and in a British outbreak strain from 2000. Most isolates (28 of 30) also had bla(OXA-51). We conclude that bla(OXA-58) is geographically widespread and has occurred in Acinetobacter spp. for over 10 years.
引用
收藏
页码:756 / 758
页数:3
相关论文
共 24 条
  • [1] Biochemical characteristics of a carbapenemase from an Acinetobacter baumannii isolate collected in Buenos Aires, Argentina
    Afzal-Shah, M
    Villar, HE
    Livermore, DM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (01) : 127 - 131
  • [2] Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii
    Afzal-Shah, M
    Woodford, N
    Livermore, DM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) : 583 - 588
  • [3] Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital
    Ayan, M
    Durmaz, R
    Aktas, E
    Durmaz, B
    [J]. JOURNAL OF HOSPITAL INFECTION, 2003, 54 (01) : 39 - 45
  • [4] The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents
    Brown, S
    Amyes, SGB
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (04) : 326 - 329
  • [5] Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina
    Brown, S
    Young, HK
    Amyes, SGB
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (01) : 15 - 23
  • [6] Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula
    Da Silva, GJ
    Quinteira, S
    Bértolo, E
    Sousa, JC
    Gallego, L
    Duarte, A
    Peixe, L
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (01) : 255 - 258
  • [7] Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil
    Dalla-Costa, LM
    Coelho, JM
    Souza, HAPHM
    Castro, MES
    Stier, CJN
    Bragagnolo, KL
    Rea-Neto, A
    Penteado, SR
    Livermore, DM
    Woodford, N
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (07) : 3403 - 3406
  • [8] Acinetobacter species identification by using tRNA spacer fingerprinting
    Ehrenstein, B
    Bernards, AT
    Dijkshoorn, L
    GernerSmidt, P
    Towner, KJ
    Bouvet, PJM
    Daschner, FD
    Grundmann, H
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (10) : 2414 - 2420
  • [9] Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936)
    Henwood, CJ
    Gatward, T
    Warner, M
    James, D
    Stockdale, MW
    Spence, RP
    Towner, KJ
    Livermore, DM
    Woodford, N
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (03) : 479 - 487
  • [10] Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii
    Héritier, C
    Poirel, L
    Lambert, T
    Nordmann, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) : 3198 - 3202